Influenza drug Molnupiravir reduces risk of death in Covid patients: DAK

Srinagar, Dec 29: With the approval of influenza drug Molnupiravir for Covid-19 patients, Doctors Association Kashmir (DAK) on Wednesday said the drug reduces the risk of hospitalization and death in Covid patients.“Molnupiravir…